DOCK2-IN-1
DOCK2-IN-1 (compound 3), a CPYPP (HY-110100) analogue, is an inhibitor of DOCK2 as well (IC50=19.1 μM) . DOCK2-IN-1 binds to DOCK2 DHR-2 domain in a reversible manner to inhibits its catalytic activity. DOCK2-IN-1 blocks the activation of both chemokine receptor- and antigen receptor-mediated Rac in lymphocytes. DOCK2-IN-1 significantly suppresses chemotactic response and T cell activation[1].
Product Specifications
CAS Number
[4590-86-7]
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
DOCK
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/dock2-in-1.html
Concentration
10mM
Purity
98.29
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1NN(C(/C1=C/C2=C(Cl)C=CC=C2)=O)C3=CC=CC=C3
Molecular Formula
C16H11ClN2O2
Molecular Weight
298.72
Precautions
H302, H315, H319
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
DOCK2
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
